Veterinary Antimicrobial Susceptibility Testing Market Size, Industry Outlook Report, Regional Analysis, Application Development, Price Trends, Competitive Market Share & Forecast, 2025 - 2034
Report ID: GMI5535
Download Free PDF
Authors:
Monali Tayade,
Veterinary Antimicrobial Susceptibility Testing Market Size
The global veterinary antimicrobial susceptibility testing market generated notable revenues in 2024 and is expected to grow at a decent CAGR during 2025 to 2034, driven by rising concerns over antimicrobial resistance (AMR) in both humans and animals, the growing demand for safe and effective veterinary treatments, and increasing awareness regarding animal health and the need for precise treatment approaches.
According to the World Health Organization (WHO), antimicrobial resistance in animals is a growing concern globally, with antibiotics in veterinary care often being overused or misused, contributing to the emergence of resistant strains. As antimicrobial resistance continues to be a significant global health threat, the veterinary sector’s need for accurate diagnostic tools, like antimicrobial susceptibility tests, becomes more crucial. These tests help identify the most effective antibiotics for treating infections in animals, improving both animal and human health by reducing the transmission of resistant pathogens.
As AMR poses serious risks to both human and animal health, governments, veterinary professionals, and researchers are working toward better solutions, including improved AST methods. Additionally, stricter regulations in several regions require veterinarians to conduct AST on infections to ensure the proper antibiotic treatment, driving demand for these diagnostic tools. However, the high cost of automated AST instruments and the lack of standardized testing practices across regions may limit the market growth.
Veterinary Antimicrobial Susceptibility Testing Market Trends
The veterinary antimicrobial susceptibility testing industry is witnessing a significant trend toward the automation of testing processes. The automation of antimicrobial susceptibility testing (AST) instruments is helping transform the veterinary diagnostic landscape. Automated systems provide faster, more accurate results than traditional methods, making them increasingly popular among veterinary professionals. Additionally, these systems help reduce human error and labor costs, improving the efficiency and reliability of testing, which is critical when managing large numbers of animals in commercial or clinical settings.
Furthermore, innovations in testing platforms and the growing popularity of point-of-care diagnostic tools are expected to revolutionize the market. The demand for faster and more efficient testing methods that deliver actionable results in real-time is increasing. This trend is particularly evident in the companion animal segment, where pet owners are more likely to seek immediate and reliable treatment for their pets.
Veterinary Antimicrobial Susceptibility Testing Market Analysis
Based on product type, the veterinary antimicrobial susceptibility testing industry is divided into automated AST instruments and manual AST kits. Automated AST instruments are expected to hold the largest market share during 2025-2034. These systems offer numerous advantages over manual methods, such as higher throughput, reduced turnaround time, and increased accuracy. Automated AST instruments can test large numbers of bacterial isolates from animal infections quickly and accurately, helping veterinary professionals choose the most appropriate antibiotics for treatment.
Automated antimicrobial susceptibility testing (AST) instruments are becoming increasingly essential in veterinary medicine due to their high efficiency, speed, and accuracy. These systems significantly reduce the time needed to perform tests, with results typically available in a few hours instead of several days. This is particularly critical for livestock farms or large animal care centers, where quick decision-making is vital to control outbreaks and ensure the timely administration of antibiotics.
Automated systems also provide more reliable and reproducible results compared to manual methods, reducing human errors that may occur during manual processes. These machines employ advanced technologies, such as microdilution and disk diffusion, to test bacterial isolates against various antimicrobial agents. These instruments help veterinarians determine the optimal treatment regimen, particularly for hard-to-treat infections or multi-drug-resistant pathogens.
In terms of animal type, the veterinary antimicrobial susceptibility testing market is segmented into livestock and companion animals. The livestock segment holds the largest market share through 2034 due to the widespread use of antibiotics in food-producing animals to prevent and treat infections. As the global demand for animal-based food products increases, the need for effective infection management in livestock is growing, leading to higher demand for antimicrobial susceptibility testing. Ensuring that animals receive the correct antibiotic treatment not only improves animal welfare but also prevents the development of antimicrobial-resistant pathogens that could impact both animal and human populations.
Livestock, including cattle, poultry, and swine, are at higher risk for infections due to the dense farming environments they are often kept in. As a result, the overuse and misuse of antibiotics in these animals are significant concerns, contributing to the rise of antimicrobial resistance.
In livestock farming, ensuring the appropriate use of antibiotics is crucial for maintaining animal health and preventing the spread of resistant bacteria. Veterinary AST helps in identifying the most effective treatment options for infections in livestock, which is crucial for both animal welfare and food safety. Furthermore, with increasing concerns over foodborne illnesses and the transfer of resistant bacteria from animals to humans, the need for accurate and reliable antimicrobial susceptibility testing is more important than ever.
North America veterinary antimicrobial susceptibility testing market is expected to hold the largest share of the market during 2025 to 2034. The region's dominance is attributed to several factors, including the high adoption rate of advanced veterinary technologies, a well-established healthcare infrastructure, and increasing awareness of the importance of antimicrobial resistance in both animals and humans. In the United States and Canada, regulatory agencies such as the U.S. Food and Drug Administration (FDA) and Health Canada are actively working to reduce the overuse of antibiotics in animals and promote responsible antibiotic stewardship. This includes the mandatory use of antimicrobial susceptibility testing in some instances to ensure the correct use of antibiotics. These regulations are expected to boost the demand for veterinary AST instruments in the region.
Furthermore, the increasing number of veterinary clinics and the rising awareness among pet owners in North America regarding the health risks associated with antimicrobial resistance are contributing to the growth of the market. The growing pet population and the increasing incidence of infectious diseases in companion animals further drive the demand for accurate and effective diagnostic tools.
Veterinary Antimicrobial Susceptibility Testing Market Share
Key players in the veterinary antimicrobial susceptibility testing industy include companies such as:
These companies are actively involved in developing and manufacturing advanced automated AST systems and manual testing kits. The competitive landscape is characterized by ongoing innovation and technological advancements aimed at improving the efficiency and accuracy of AST processes. Additionally, several players are focusing on expanding their product portfolios to cater to the growing demand for point-of-care diagnostic solutions, further strengthening their position in the market.
Veterinary Antimicrobial Susceptibility Testing Market News:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →